Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Dual Targeting of Cell-Cycle Checkpoint Kinase and Unfolded Protein Response As a Novel Therapeutic Approach for High-Risk Multiple Myeloma with TP53 Deletion or Mutations

Yuka Tanaka, MD, Takayuki Tabayashi, MD PhD, Yasuyuki Takahashi, MD PhD, Yuta Kimura, MD, Tatsuki Tomikawa, MD PhD, Junichi Watanabe, MD PhD, Tomoe Anan-Nemoto, MD PhD, Morihiko Sagawa, MD PhD, Reiko Watanabe, MD PhD, Michihide Tokuhira, Masahiro Kizaki, MD PhD

Blood (2018) 132 (Supplement 1): 5613.

https://doi.org/10.1182/blood-2018-99-116247

Published: 2018

Journal Articles

The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

Michihide Tokuhira, Yuta Kimura, MD, Yuka Tanaka, MD, Yasuyuki Takahashi, MD PhD, Tatsuki Tomikawa, MD PhD, Junichi Watanabe, MD PhD, Tomoe Anan-Nemoto, MD PhD, Morihiko Sagawa, MD PhD, Shuji Momose, MD PhD, Morihiro Higashi, MD PhD, Tabayashi Takayuki, MD PhD, Reiko Nakaseko, MD PhD, Jun-ichi Tamaru, MDPhD, Masahiro Kizaki, MDPhD

Blood (2018) 132 (Supplement 1): 1589.

https://doi.org/10.1182/blood-2018-99-114382

Published: 2018

Journal Articles

Predictive Significance of Serum Beta 2-Microglobulin Levels and M-Protein Velocity for Symptomatic Progression of Smoldering Multiple Myeloma

Tsuyoshi Muta, MDPhD, Shinsuke Iida, MD PhD, Kosei Matsue, MD PhD, Kazutaka Sunami, Jun Isoda, MD PhD, Naoko Harada, MD PhD, Yoshio Saburi, MD PhD, Seiichi Okamura, MD PhD, Kyouya Kumagae, MD PhD, Junichi Watanabe, MD PhD, Junya Kuroda, MD PhD, Kenichi Aoki, MD, Ryosuke Ogawa, MD PhD, Toshihiro Miyamoto, MD PhD, Koichi Akashi, MD PhD, Yasushi Takamatsu, MD PhD

Blood (2014) 124 (21): 3379.

https://doi.org/10.1182/blood.V124.21.3379.3379

Published: 2014

Journal Articles

Treatment of Idiopathic Myelofibrosis Employing siRNA for Heat Shock Protein 47 (siRNA/HSP47) Encapsulated in Liposomes.

Junichi Watanabe, MD, Takuya Matsunaga, MD, PhD, Kazuyuki Murase, MD, PhD, Yasushi Sato, MD, PhD, Taiko Nagaya, Hirotoshi Ishiwatari, MD, Sho Takahashi, MD, PhD, Koichi Takada, MD, PhD, Masayoshi Kobune, MD, PhD, Kazuya Shimoda, MD, PhD, Mine Harada, MD, PhD, Yoshiro Niitsu, MD, PhD

Blood (2007) 110 (11): 4646.

https://doi.org/10.1182/blood.V110.11.4646.4646

Published: 2007

Journal Articles

Augmented Proliferation of Human Alveolar Macrophages After Allogeneic Bone Marrow Transplantation

Koh Nakata, Hajime Gotoh, Junichi Watanabe, Takeshi Uetake, Iwao Komuro, Kazumi Yuasa, Shinya Watanabe, Ryuji Ieki, Hisashi Sakamaki, Hideki Akiyama, Shohji Kudoh, Makoto Naitoh, Hitoshi Satoh, Kaoru Shimada

Blood (1999) 93 (2): 667–673.

https://doi.org/10.1182/blood.V93.2.667

Published: 1999

NARROW

Dual Targeting of Cell-Cycle Checkpoint Kinase and Unfolded Protein Response As a Novel Therapeutic Approach for High-Risk Multiple Myeloma with TP53 Deletion or Mutations

The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

Predictive Significance of Serum Beta 2-Microglobulin Levels and M-Protein Velocity for Symptomatic Progression of Smoldering Multiple Myeloma

Treatment of Idiopathic Myelofibrosis Employing siRNA for Heat Shock Protein 47 (siRNA/HSP47) Encapsulated in Liposomes.

Augmented Proliferation of Human Alveolar Macrophages After Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Dual Targeting of Cell-Cycle Checkpoint Kinase and Unfolded Protein Response As a Novel Therapeutic Approach for High-Risk Multiple Myeloma with TP53 Deletion or Mutations

The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

Predictive Significance of Serum Beta 2-Microglobulin Levels and M-Protein Velocity for Symptomatic Progression of Smoldering Multiple Myeloma

Treatment of Idiopathic Myelofibrosis Employing siRNA for Heat Shock Protein 47 (siRNA/HSP47) Encapsulated in Liposomes.

Augmented Proliferation of Human Alveolar Macrophages After Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only